Clinical trial
Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety…
NCT00418379 · Stallergenes Greer, Industry · Completed
Key facts
| NCT number | NCT00418379 |
|---|---|
| Title | Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets |
| Official title | A Randomised, Double-blind, Placebo-controlled, Multi-national, Multi-centre, Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of Two Dosing Regimens of 300 IR Sublingual Immunotherapy (SLIT) Administered as Allergen-based Tablets Once Daily to Patients Suffering From… |
| Lead sponsor | Stallergenes Greer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Allergy |
| Intervention type | Drug |
| Interventions | 300 IR (4M), 300 IR (2M), Placebo |
| Enrollment | 633 |
| Start date | Dec 1, 2006 |
| Primary completion | Aug 1, 2010 |
| Completion | Sep 1, 2011 |
| First posted | Jan 4, 2007 |
| Last update posted | May 25, 2016 |
| Countries | France |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: